Analysts think MBIO stock price could increase by 7356%
Jun 14, 2024, 6:29 AM
224.85%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, specializes in developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company, which went public in 2017, collaborates with notable medical centers like City of Hope and Fred Hutchinson Cancer Center to advance its CAR T therapy pipeline targeting various cancer markers.
3 analysts think MBIO stock price will increase by 7356.14%. The current median analyst target is $10.20 compared to a current stock price of $0.14. The lowest analysts target is $10.10 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.